A Study of the Safety and Efficacy of Calcipotriol and Betamethasone Dipropionate Scalp Formulation in the Long-Term Management of Scalp Psoriasis
Authors:
- 12 September 2008
- journal article
- research article
- Published by S. Karger AG in Dermatology
- Vol. 217 (4) , 321-328
Abstract
Background: Effective and safe products are needed for long-term management of scalp psoriasis. This study investigated the long-term safety and efficacy of a two-compound formulation (calcipotriol 50 µg/g plus betamethasone dipropionate 0.5 mg/g) for scalp psoriasis. Methods: In this 52-week, international, double-blind study, 869 patients with moderate-to-severe scalp psoriasis were randomized to either a two-compound scalp formulation (n = 429) or calcipotriol (n = 440). Results: Adverse drug reactions were less frequent in the two-compound group compared with the calcipotriol group (17.2 vs. 29.5%; p < 0.001). Incidences of adverse events possibly associated with long-term corticosteroid use were low in both the two-compound (2.6%) and the calcipotriol (3.0%) groups. Disease was satisfactorily controlled in 92.3% of visits in the two-compound group versus 80.0% in the calcipotriol group (p < 0.001). Conclusion: The two-compound scalp formulation demonstrated a high level of safety and efficacy in long-term management of scalp psoriasis.Keywords
This publication has 21 references indexed in Scilit:
- A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet® /Daivobet® /Taclonex® ) in the treatment of psoriasis vulgarisBritish Journal of Dermatology, 2006
- Calcipotriol/betamethasone dipropionate for the treatment of psoriasisExpert Opinion on Pharmacotherapy, 2006
- A randomized, investigator‐masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasisJournal of Dermatological Treatment, 2006
- Consistency of data in six phase III clinical studies of a two‐compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasisJournal of the European Academy of Dermatology and Venereology, 2005
- Psoriasis treatment: traditional therapyAnnals of the Rheumatic Diseases, 2005
- Objective Assessment of Compliance With Psoriasis TreatmentArchives of Dermatology, 2004
- Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacyBritish Journal of Dermatology, 1998
- Scalp Psoriasis, Clinical Presentations and Therapeutic ManagementDermatology, 1998
- Natural history and treatment of scalp psoriasis.1992
- Dose-dependent effect of topical corticosteroids on blood flow in human cutaneous tissueActa Dermato-Venereologica, 1978